Pacira Biosciences Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
43.12USD
24 Jun 2019
43.12USD
24 Jun 2019
Change (% chg)
$-0.00 (-0.00%)
$-0.00 (-0.00%)
Prev Close
$43.12
$43.12
Open
$43.96
$43.96
Day's High
$43.96
$43.96
Day's Low
$42.75
$42.75
Volume
120,888
120,888
Avg. Vol
180,476
180,476
52-wk High
$54.92
$54.92
52-wk Low
$30.00
$30.00
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.35 | December | 25 Jun 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 2 |
| (2) OUTPERFORM | 6 | 5 | 5 | 5 |
| (3) HOLD | 8 | 8 | 6 | 6 |
| (4) UNDERPERFORM | 0 | 0 | 1 | 1 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.53 | 2.56 | 2.60 | 2.60 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 16 | 100.70 | 103.50 | 94.70 | 85.56 |
| Quarter Ending Sep-19 | 16 | 104.52 | 108.80 | 102.60 | 85.13 |
| Year Ending Dec-19 | 17 | 415.08 | 421.10 | 405.00 | 362.07 |
| Year Ending Dec-20 | 17 | 475.23 | 527.25 | 423.87 | 412.29 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 16 | 0.35 | 0.42 | 0.19 | 0.18 |
| Quarter Ending Sep-19 | 16 | 0.40 | 0.51 | 0.27 | 0.16 |
| Year Ending Dec-19 | 16 | 1.57 | 1.69 | 1.18 | 0.98 |
| Year Ending Dec-20 | 16 | 2.31 | 2.93 | 1.52 | 1.77 |
| LT Growth Rate (%) | 2 | 42.70 | 46.20 | 39.20 | 62.25 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-19 | 92.19 | 91.31 | 0.88 | 0.95 |
| Quarter Ending Dec-18 | 93.69 | 95.11 | 1.42 | 1.52 |
| Quarter Ending Sep-18 | 80.18 | 83.45 | 3.26 | 4.07 |
| Quarter Ending Jun-18 | 79.13 | 81.11 | 1.98 | 2.50 |
| Quarter Ending Mar-18 | 73.83 | 74.61 | 0.77 | 1.05 |
| Earnings (per share) | ||||
| Quarter Ending Mar-19 | 0.26 | 0.22 | 0.04 | 15.61 |
| Quarter Ending Dec-18 | 0.28 | 0.47 | 0.19 | 70.72 |
| Quarter Ending Sep-18 | 0.08 | 0.31 | 0.23 | 284.14 |
| Quarter Ending Jun-18 | 0.07 | 0.24 | 0.17 | 226.53 |
| Quarter Ending Mar-18 | 0.02 | 0.02 | 0.00 | 16.32 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 100.70 | 100.70 | 100.38 | 98.27 | 85.56 |
| Quarter Ending Sep-19 | 104.52 | 104.52 | 104.26 | 101.39 | 85.13 |
| Year Ending Dec-19 | 415.08 | 414.77 | 414.19 | 403.83 | 362.07 |
| Year Ending Dec-20 | 475.23 | 472.49 | 471.55 | 444.91 | 412.29 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 0.35 | 0.35 | 0.34 | 0.34 | 0.18 |
| Quarter Ending Sep-19 | 0.40 | 0.40 | 0.40 | 0.37 | 0.16 |
| Year Ending Dec-19 | 1.57 | 1.57 | 1.56 | 1.49 | 0.98 |
| Year Ending Dec-20 | 2.31 | 2.31 | 2.31 | 2.10 | 1.77 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-19 | 0 | 0 | 2 | 0 |
| Quarter Ending Sep-19 | 0 | 0 | 2 | 0 |
| Year Ending Dec-19 | 0 | 0 | 2 | 0 |
| Year Ending Dec-20 | 0 | 0 | 2 | 0 |
| Earnings | ||||
| Quarter Ending Jun-19 | 0 | 0 | 1 | 0 |
| Quarter Ending Sep-19 | 0 | 0 | 0 | 1 |
| Year Ending Dec-19 | 0 | 0 | 1 | 0 |
| Year Ending Dec-20 | 0 | 0 | 1 | 0 |
Earnings vs. 
Estimates